Search

Your search keyword '"Rocha-Singh K"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Rocha-Singh K" Remove constraint Author: "Rocha-Singh K"
75 results on '"Rocha-Singh K"'

Search Results

1. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-Month results from the IN.PACT deep randomized trial

2. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial

3. International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension

13. Hypercalcemia, nausea, years of bloody diarrhea

16. Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial.

17. International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension

18. Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.

19. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.

20. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort.

22. Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study.

23. An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial.

24. Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.

25. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.

26. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial.

27. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.

28. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.

29. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

30. Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model.

31. A controlled trial of renal denervation for resistant hypertension.

32. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.

33. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study.

34. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.

35. Feasibility of FiberNet® embolic protection system in patients undergoing angioplasty for atherosclerotic renal artery stenosis.

36. Stroke intervention: catheter-based therapy for acute ischemic stroke.

37. Heparin-induced thrombocytopenia with thrombosis after endovascular aneurysm repair.

38. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial.

39. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.

41. Percutaneous vascular interventions in renal artery diseases.

42. Functional and clinical outcomes of nitinol stenting with and without abciximab for complex superficial femoral artery disease: a randomized trial.

43. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study.

44. Femoropopliteal subintimal angioplasty and nitinol stenting: a marriage of technique and technology...but will it last?

45. Renal and iliac artery stenting by interventional cardiologists and vascular surgeons: the Foundation to Advance Medical Education (FAME) initiative.

46. The peripheral artery questionnaire: a new disease-specific health status measure for patients with peripheral arterial disease.

49. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.

Catalog

Books, media, physical & digital resources